Don't miss it.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

SPECIAL OPPORTUNITIES Nvidia's Favorite Biotech to Make Historic Announcement as Soon as July 1 Justin Fritz-Rushing | Editorial Director | The Oxford Club Dear Reader, Get ready... As soon as July 1, a major announcement from a small biotech company could upend the $11 trillion healthcare, life sciences, and pharma industries. That's likely why tech titan Nvidia has made a stunning move by making a huge investment in this $10 biotech stock. In fact, Nvidia is so confident, that a shocking 97% of its investment portfolio is concentrated in just two holdings - with this tiny firm being one of them. In other words, this is no ordinary biotech... Its breakthrough is so innovative that a top pharma exec recently declared it "...could be one of the most disruptive technologies of our time." Yet I doubt 1 in 1,000 investors even knows it exists. That's all set to change following the big announcement... coming as soon as July 1. Which is why Marc Lichtenfeld - America's leading stock catalyst expert - has scheduled an exclusive event just ahead of the big news. Join him on June 27 at 2 p.m. ET to get the full details on this biotech firm's disruptive AI-driven technology... as well as the story behind Nvidia's surprising investment. Plus so much more, including the chance to see how to optimally position yourself ahead of this potential mania. Just click here to reserve your spot. This is shaping up to be one of the biggest investment opportunities in recent memory. Don't miss it. Sincerely, Justin You are receiving this email as a part of your membership in The Oxford Club. Oxford Club Special Opportunities is published by The Oxford Club. To unsubscribe from opportunity based emails like this one, click here. Please note that this will not impact the fulfillment of your subscription in any way.. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist The Oxford Club Special Opportunities © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.